Save on Antidepressants in Maryland
Compare Antidepressants prices across Maryland pharmacies. Save up to 77% — no insurance required.
Top Antidepressants for Maryland Residents
Sertraline (Zoloft)
Fluoxetine (Prozac)
Escitalopram (Lexapro)
Venlafaxine (Effexor)
Bupropion (Wellbutrin)
Maryland Prescription Assistance Programs
SPDAP (Senior Prescription Drug Assistance Program)
Subsidises Medicare Part D premiums and cost-sharing for eligible low-income Maryland seniors and adults with disabilities.
Eligibility: Maryland residents aged 65+ (or adults with disabilities) enrolled in Medicare Part D with income between 100-300% FPL. Contact the Maryland Department of Aging at 1-800-243-3425.
Maryland Medicaid Rx
Comprehensive prescription drug coverage through Maryland Medicaid (HealthChoice) managed care for eligible residents.
Eligibility: Low-income Maryland adults up to 138% FPL, children, pregnant women, and people with disabilities.
Frequently Asked Questions
What is the cheapest antidepressant available?
Generic fluoxetine and generic sertraline are typically $5–$15/month and are among the most affordable prescription drugs overall. ScriptUnlock bids often surface prices below $10.
How much can I save switching from Lexapro to generic escitalopram?
Brand Lexapro lists at $200–$300/month without insurance; generic escitalopram is $10–$25. ScriptUnlock bids make this comparison instantaneous.
Is bupropion (Wellbutrin) available as a generic?
Yes. Generic bupropion IR, SR, and XL formulations are all available at low cost. Savings versus brand Wellbutrin XL can be $200+/month.
Can I use ScriptUnlock for MAOIs or TCAs?
Yes. Older antidepressants like phenelzine, tranylcypromine, and amitriptyline are included in the ScriptUnlock formulary. Generic versions are typically very affordable.
How long before I can tell if an antidepressant is working?
Most antidepressants take 4–8 weeks for full therapeutic effect. Consistent, uninterrupted treatment is essential — ScriptUnlock helps remove cost as a barrier to adherence.